# Natrecor in Pulmonary Hypertension

> **NCT00075179** · PHASE4 · TERMINATED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Pulmonary Hypertension
- Cancer
- Lung Disease
- Cardiothoracic Surgery

## Interventions

- **DRUG:** Nesiritide (Natrecor)
- **PROCEDURE:** Right Heart Catheterization

## Key facts

- **NCT ID:** NCT00075179
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-12-31
- **Primary completion:** 2006-03-28
- **Final completion:** 2006-03-28
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Low accrual.
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075179, "Natrecor in Pulmonary Hypertension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00075179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*